Ana-Guard Side Effects

Generic name: epinephrine

Medically reviewed by Drugs.com. Last updated on Apr 25, 2024.

Note: This document provides detailed information about Ana-Guard Side Effects associated with epinephrine. Some dosage forms listed on this page may not apply specifically to the brand name Ana-Guard.

Applies to epinephrine: injection solution.

Other dosage forms:

• inhalation aerosol liquid

Serious side effects of Ana-Guard

Along with its needed effects, epinephrine (the active ingredient contained in Ana-Guard) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking epinephrine:

Incidence not known

• abnormal or decreased touch sensation
• anxiety
• arm, back, or jaw pain
• bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
• blurred vision
• chest pain, tightness, heaviness, or discomfort
• cold, pale, or bluish color of the skin of the fingers or toes
• confusion
• difficulty in speaking
• dizziness
• double vision
• fainting
• fast, slow, irregular, pounding, or racing heartbeat or pulse
• headache
• inability to move the arms, legs, or facial muscles
• inability to speak
• nausea
• numbness, tingling, or pain in the fingers
• paleness of the skin
• pounding in the ears
• restlessness
• shakiness in the legs, arms, hands, or feet
• slow speech
• sweating
• trembling or shaking of the hands or feet
• trouble breathing
• unusual tiredness or weakness
• vomiting

Get emergency help immediately if any of the following symptoms of overdose occur while taking epinephrine:

Symptoms of overdose

• agitation
• coldness of the skin
• confusion
• decreased awareness or responsiveness
• decreased urine output
• depression
• drowsiness
• hostility
• irritability
• lightheadedness
• loss of consciousness
• muscle twitching
• rapid weight gain
• rapid, deep breathing
• seizures
• severe sleepiness
• stomach cramps
• swelling of the face, ankles, or hands
• unusual drowsiness, dullness, or feeling of sluggishness

For healthcare professionals

Applies to epinephrine: compounding powder, inhalation aerosol, inhalation solution, injectable kit, injectable solution, intravenous solution, nasal spray, subcutaneous suspension.

General adverse events

Due to the lack of randomized, controlled clinical trials for the treatment of anaphylaxis, the true incidence of adverse reactions associated with the systemic use of this drug is difficult to determine. The most commonly reported adverse reactions include anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.^[Ref]

Cardiovascular

• Frequency not reported: Tachycardia, supraventricular tachycardia, ventricular arrhythmias, myocardial ischemia, myocardial infarction, limb/peripheral ischemia, palpitations, angina, arrhythmias, hypertension, vasoconstriction, ventricular ectopy, ventricular fibrillation, cold extremities, electrocardiogram changes, stress cardiomyopathy^[Ref]

Nervous system

• Frequency not reported: Headache, paresthesia, tremor, stroke, central nervous system bleeding, dizziness, cerebral hemorrhage, memory impaired, lightheadedness, psychomotor agitation, tingling, Parkinsonism aggravated, syncope, convulsions, subarachnoid hemorrhage, hemiplegia^[Ref]

Psychiatric

• Frequency not reported: Nervousness, excitability, anxiety, apprehension, restlessness, disorientation, panic, hallucinations, psychosis, fear, sleeplessness/insomnia, tenseness, confusion, irritability^[Ref]

Local

• Frequency not reported: Extravasation, injection site pallor, coldness at injection site, hypoesthesia at injection site, injury at injection site, local ischemic necrosis^[Ref]

Dermatologic

• Frequency not reported: Diaphoresis, pallor, piloerection, skin blanching, skin necrosis with extravasation, necrotizing fasciitis, flushing/redness of skin and face, hyperhidrosis^[Ref]

Metabolic

• Frequency not reported: Hypoglycemia, hyperglycemia, insulin resistance, hypokalemia, lactic acidosis, insulin secretion inhibited, metabolic acidosis, anorexia^[Ref]

Respiratory

• Frequency not reported: Pulmonary edema, rales, respiratory difficulty, dyspnea, bronchospasm, hypoxia of mucosa^[Ref]

Renal

• Frequency not reported: Renal insufficiency^[Ref]

Hypersensitivity

Hypersensitivity side effects have been extremely unusual. Contact dermatitis has been associated with ocularly applied epinephrine (the active ingredient contained in Ana-Guard) These reactions have typically presented with lid edema and a thick yellow discharge.

Gastrointestinal

• Frequency not reported: Nausea, vomiting, bowel necrosis, hypersalivation^[Ref]

Genitourinary

• Frequency not reported: Urinary retention, difficult micturition^[Ref]

Hematologic

• Frequency not reported: Thrombocytosis^[Ref]

Musculoskeletal

• Frequency not reported: Myonecrosis^[Ref]

Other

• Frequency not reported: Chest pain, weakness, gas gangrene, asthenia^[Ref]

Ocular

• Frequency not reported: Corneal endothelial damage^[Ref]

Endocrine

• Frequency not reported: Growth hormone secretion stimulated^[Ref]

Frequently asked questions

• Can you use an expired EpiPen in an emergency?
• Norepinephrine vs epinephrine: what's the difference?
• Can you bring an EpiPen on a plane?
• What's the mechanism of action for epinephrine?
• Does epinephrine cause vasoconstriction?
• How does neffy work?
• How much does Auvi-Q cost compared to EpiPen?

Further information

Ana-Guard side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer